Trial Profile
The Effects and Side Effects of ITS2357 in Autoinflammatory Syndromes
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2022
Price :
$35
*
At a glance
- Drugs Givinostat (Primary)
- Indications Hereditary autoinflammatory diseases
- Focus Therapeutic Use
- 31 Jan 2017 New trial record